MetaADEDB 2.0 @ LMMD
Dextroamphetamine
(KWTSXDURSIMDCE-QMMMGPOBSA-N)
Structure
SMILES
C[C@@H](Cc1ccccc1)N
Type(s)
Approved; Illicit
ATC code(s)
N06BA02
Molecular Formula:
C9H13N
Molecular Weight:
135.206
Log P:
2.2766
Hydrogen Bond Acceptor:
1
Hydrogen Bond Donor:
1
TPSA:
26.02
CAS Number(s):
51-64-9
Synonym(s)
1.
Dextroamphetamine
2.
d-Amphetamine
3.
Curban
4.
Dexamfetamine
5.
Dexamphetamine
6.
Dexedrine
7.
Dextro-Amphetamine Sulfate
8.
DextroStat
9.
Dextroamphetamine Sulfate
10.
Oxydess
11.
d-Amphetamine Sulfate
12.
dextro-Amphetamine
13.
Dextro Amphetamine Sulfate
14.
Sulfate, Dextroamphetamine
15.
d Amphetamine
16.
d Amphetamine Sulfate
17.
dextro Amphetamine
External Link(s)
MeSHD003913
PubChem Compound5826
BindingDB50022723
ChEBI4469
CHEMBLCHEMBL612
DrugBankDB01576
DrugCentral841
IUPHAR/BPS Guide to PHARMACOLOGY2147
KEGGcpd:C07884
dr:D03740
Therapeutic Target DatabaseD0T3LF
D0U5GS
ZINC6021033
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 94
Canada Vigilance: 15
Canada Vigilance
US FAERS
2Product substitution issueFAERS: 30
Canada Vigilance: 6
Canada Vigilance
US FAERS
3Pharmaceutical product complaintFAERS: 26US FAERS
4HeadacheFAERS: 19
Canada Vigilance: 9
4562464CTD
Canada Vigilance
US FAERS
5DizzinessFAERS: 15
Canada Vigilance: 3
9455325CTD
Canada Vigilance
US FAERS
6FatigueFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
7Therapeutic response unexpected with drug substitutionFAERS: 13US FAERS
8Product quality issueFAERS: 11
Canada Vigilance: 3
Canada Vigilance
US FAERS
9Feeling abnormalFAERS: 10
Canada Vigilance: 3
Canada Vigilance
US FAERS
10MalaiseFAERS: 8
Canada Vigilance: 6
Canada Vigilance
US FAERS
11SomnolenceFAERS: 8
Canada Vigilance: 4
Canada Vigilance
US FAERS
12NauseaFAERS: 7
Canada Vigilance: 4
Canada Vigilance
US FAERS
13AgitationFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
14HypersomniaFAERS: 6US FAERS
15PalpitationsFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
16Adverse eventFAERS: 5US FAERS
17CryingFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
18Drug administration errorFAERS: 5US FAERS
19LethargyFAERS: 54191448CTD
US FAERS
20Product formulation issueFAERS: 5US FAERS
21TremorFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
22Abdominal PainFAERS: 4
Canada Vigilance: 2
4562464
7202238
CTD
Canada Vigilance
US FAERS
23AngerFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
24AnxietyFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
25Chest PainFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
26Educational problemFAERS: 4US FAERS
27NervousnessFAERS: 4US FAERS
28Oropharyngeal painFAERS: 4US FAERS
29OverdoseFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
30VomitingFAERS: 4
Canada Vigilance: 4
Canada Vigilance
US FAERS
31ArthralgiaFAERS: 3US FAERS
32AstheniaFAERS: 3US FAERS
33Drug withdrawal syndromeFAERS: 3US FAERS
34Medication ErrorFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
35Memory impairmentFAERS: 3US FAERS
36Mood swingsFAERS: 3US FAERS
37MydriasisFAERS: 3
Canada Vigilance: 3
648586CTD
Canada Vigilance
US FAERS
38NarcolepsyFAERS: 34359162CTD
US FAERS
39Therapeutic response unexpectedFAERS: 3US FAERS
40UrticariaFAERS: 3US FAERS
41Weight decreasedFAERS: 3US FAERS
42YawningFAERS: 3US FAERS
43Abdominal discomfortFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
44Activities of daily living impairedFAERS: 2US FAERS
45Acute kidney injuryFAERS: 2US FAERS
46Acute myocardial infarctionFAERS: 2US FAERS
47Alanine Aminotransferase IncreasedFAERS: 2US FAERS
48AphasiaFAERS: 2US FAERS
49Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
50Atrial FibrillationFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
51BedriddenFAERS: 2US FAERS
52Blood glucose fluctuationFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
53Blood sodium decreasedFAERS: 2US FAERS
54Completed SuicideFAERS: 2US FAERS
55Depressed moodFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
56DysarthriaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
57Economic problemFAERS: 2US FAERS
58ErythemaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
59Growth retardationFAERS: 2US FAERS
60HemiparesisFAERS: 2US FAERS
61HyperreflexiaFAERS: 2US FAERS
62Metabolic acidosisFAERS: 2US FAERS
63Personality ChangeFAERS: 2US FAERS
64Product measured potency issueFAERS: 2US FAERS
65Pulmonary HypertensionFAERS: 2US FAERS
66SwellingFAERS: 2US FAERS
67TachycardiaFAERS: 2US FAERS
68ThrombocytopeniaFAERS: 2US FAERS
69Toxicity to various agentsFAERS: 2US FAERS
70Unevaluable eventFAERS: 2US FAERS
71Acute Lung InjuryFAERS: 1US FAERS
72AlopeciaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
73Anion GapFAERS: 1US FAERS
74Anion gap abnormalFAERS: 1US FAERS
75AnorexiaFAERS: 14564954
7202238
CTD
US FAERS
76ApathyFAERS: 1US FAERS
77AsthmaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
78AtaxiaFAERS: 12498959CTD
US FAERS
79BelligerenceFAERS: 1US FAERS
80Blood glucose increasedFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
81Cerebrovascular accidentFAERS: 1US FAERS
82ClonusFAERS: 1US FAERS
83ConstipationFAERS: 1US FAERS
84CyanosisFAERS: 1US FAERS
85DehydrationFAERS: 1US FAERS
86Delayed PubertyFAERS: 1US FAERS
87DeliriumFAERS: 1US FAERS
88Drug ToleranceFAERS: 1US FAERS
89Drug abuseFAERS: 1US FAERS
90Drug exposure during pregnancyFAERS: 1US FAERS
91DysgeusiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
92DyspepsiaFAERS: 1US FAERS
93DysphasiaFAERS: 1US FAERS
94DysphoniaFAERS: 1US FAERS
95Elevated moodFAERS: 1US FAERS
96Erectile dysfunctionFAERS: 1US FAERS
97Excessive eye blinkingFAERS: 1US FAERS
98Feeling jitteryFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
99FlushingFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
100Gastric BypassFAERS: 1US FAERS
101Gastrointestinal wall thickeningFAERS: 1US FAERS
102HalitosisFAERS: 1US FAERS
103Heart sounds abnormalFAERS: 1US FAERS
104HepatotoxicityFAERS: 1US FAERS
105HerniaFAERS: 1US FAERS
106HydrocephalusFAERS: 1US FAERS
107HyperacusisFAERS: 1US FAERS
108HyperchlorhydriaFAERS: 1US FAERS
109HyperventilationFAERS: 1US FAERS
110HypomaniaFAERS: 1US FAERS
111HypotensionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
112Impaired driving abilityFAERS: 1US FAERS
113Impaired work abilityFAERS: 1US FAERS
114Inappropriate affectFAERS: 1US FAERS
115Intentional product use issueFAERS: 1US FAERS
116Intercepted drug dispensing errorFAERS: 1US FAERS
117Jugular vein distensionFAERS: 1US FAERS
118Loose toothFAERS: 1US FAERS
119MalnutritionFAERS: 1US FAERS
120Mental impairmentFAERS: 1US FAERS
121Mouth swellingFAERS: 1US FAERS
122Muscle RigidityFAERS: 1US FAERS
123Musculoskeletal stiffnessFAERS: 1US FAERS
124MyalgiaFAERS: 1US FAERS
125Nonspecific reactionFAERS: 1US FAERS
126Obsessive-Compulsive DisorderFAERS: 12217661
12505824
CTD
US FAERS
127Ocular icterusFAERS: 1US FAERS
128Oral pruritusFAERS: 1US FAERS
129Osmolar gap abnormalFAERS: 1US FAERS
130PainFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
131Paradoxical drug reactionFAERS: 1US FAERS
132ParanoiaFAERS: 1US FAERS
133Pharmaceutical product counterfeitFAERS: 1US FAERS
134PneumoniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
135PoisoningFAERS: 1US FAERS
136Product counterfeitFAERS: 1US FAERS
137Product label issueFAERS: 1US FAERS
138Product name confusionFAERS: 1US FAERS
139Product packaging quantity issueFAERS: 1US FAERS
140PruritusFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
141RestlessnessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
142RhabdomyolysisFAERS: 1US FAERS
143ScreamingFAERS: 1US FAERS
144Sexual DysfunctionFAERS: 1US FAERS
145Solar lentigoFAERS: 1US FAERS
146SomnambulismFAERS: 1US FAERS
147StarvationFAERS: 1US FAERS
148StomatitisFAERS: 1US FAERS
149SyncopeFAERS: 1US FAERS
150Tension HeadacheFAERS: 1US FAERS
151TetanyFAERS: 1US FAERS
152Therapeutic product ineffectiveFAERS: 1US FAERS
153Therapy changeFAERS: 1US FAERS
154Ventricular DysfunctionFAERS: 1US FAERS
155VertigoFAERS: 1US FAERS
156Accidental exposure to product by childCanada Vigilance: 1Canada Vigilance
157AmnesiaCanada Vigilance: 13227033CTD
Canada Vigilance
158Amphetamine-Related Disorders

View details

CTD
159Angina PectorisCanada Vigilance: 1Canada Vigilance
160Anxiety Disorders

View details

CTD
161AuraCanada Vigilance: 1Canada Vigilance
162Bipolar Disorder

View details

CTD
163BradycardiaCanada Vigilance: 1652837CTD
Canada Vigilance
164BruxismCanada Vigilance: 1Canada Vigilance
165Cardiomyopathies6848027CTD
166Cardiovascular Abnormalities3563934CTD
167Cardiovascular Diseases9219047CTD
168Catalepsy572550
2883335
4855871
CTD
169Cataplexy164849CTD
170Catatonia4397415CTD
171Chemical and Drug Induced Liver Injury23820845CTD
172Child Behavior Disorders4562464CTD
173Cocaine-Related Disorders

View details

CTD
174Cognition Disorders17035931CTD
175Conduct Disorder10630462CTD
176Depressive disorder

View details

CTD
177Disruptive, Impulse Control, and Conduct Disorders8956377CTD
178Drug DependenceCanada Vigilance: 1Canada Vigilance
179Drug diversionCanada Vigilance: 1Canada Vigilance
180Dyskinesia, Drug-Induced

View details

CTD
181Dystonia18315457CTD
182Epilepsy1173843CTD
183EpistaxisCanada Vigilance: 1Canada Vigilance
184Eye Abnormalities3563934CTD
185Feeding and Eating Disorders4562464
6950128
9310521
CTD
186Fetal Death3563934CTD
187Fetal Diseases3563934CTD
188Fever1242323
9164591
9795148
CTD
189Hallucinations6834023CTD
190Heart Diseases17274456CTD
191Hypokinesia945166CTD
192IncontinenceCanada Vigilance: 1Canada Vigilance
193Livedo ReticularisCanada Vigilance: 2Canada Vigilance
194Mental disorders8506450CTD
195Motion Sickness1613127CTD
196Movement Disorders11271399
18767395
CTD
197Muscle Spasticity3372709CTD
198Muscle tightnessCanada Vigilance: 1Canada Vigilance
199Myoclonus7078834CTD
200Nerve Degeneration11102570
15337264
CTD
201Neurobehavioral Manifestations

View details

CTD
202Neurotic Disorders5376593CTD
203Oral mucosal eruptionCanada Vigilance: 1Canada Vigilance
204Perceptual Disorders17035931CTD
205Peripheral Vascular Diseases18431096CTD
206Personality Disorders1168580CTD
207Poor quality sleepCanada Vigilance: 1Canada Vigilance
208Product administration errorCanada Vigilance: 1Canada Vigilance
209Product complaintCanada Vigilance: 1Canada Vigilance
210Psychoses, Substance-Induced

View details

CTD
211Psychotic Disorders6802100CTD
212Raynaud Disease18240233CTD
213Restless Legs SyndromeCanada Vigilance: 1Canada Vigilance
214Schizophrenia12503839CTD
215Seizures

View details

CTD
216Skin hypertrophyCanada Vigilance: 1Canada Vigilance
217Sleep Deprivation5938424
17484308
CTD
218Sleep Initiation and Maintenance Disorders

View details

CTD
219Sleep Wake Disorders6950128CTD
220Sperm concentration zeroCanada Vigilance: 1Canada Vigilance
221Stereotypic Movement Disorder

View details

CTD
222Substance Withdrawal Syndrome15765258
18315457
CTD
223Substance-Related Disorders6848027
7824548
CTD
224Therapeutic product effect delayedCanada Vigilance: 1Canada Vigilance
225Trisomy 21Canada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.